Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper Pallesen

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Nature Communications|May 18, 2018
Structure of a cleavage-independent HIV Env recapitulates the glycoprotein architecture of the native cleaved trimerAnita Sarkar, Shridhar Bale, Anna-Janina Behrens, et al.
Nature Microbiology|August 27, 2016
Structures of Ebola virus GP and sGP in complex with therapeutic antibodiesJesper Pallesen, Charles D Murin, Natalia de Val, et al.
Plos Pathogens|May 11, 2018
Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteinsTorben Schiffner, Jesper Pallesen, Rebecca A Russell, et al.
Trends in Biotechnology|June 19, 2026
Engineering single-dose plasmid DNA for sustained in vivo delivery of designer incretinsEbony N Gary, Yangcheng Gao, Casey E Hojecki, et al.
Cell Reports|September 26, 2019
Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTDNianshuang Wang, Osnat Rosen, Lingshu Wang, et al.
Cell Reports|May 23, 2019
The Chimpanzee SIV Envelope Trimer: Structure and Deployment as an HIV Vaccine TemplateRaiees Andrabi, Jesper Pallesen, Joel D Allen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2017
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigenJesper Pallesen, Nianshuang Wang, Kizzmekia S Corbett, et al.
Nature Medicine|October 21, 2025
Safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies in healthy adults: a phase 1 trialPablo Tebas, Ami Patel, Joseph T Agnes, et al.
Plos Pathogens|November 8, 2019
Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteinsJose A Quiroz, Ryan J Malonis, Larissa B Thackray, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Rapid elicitation of a new class of neutralizing N332-glycan independent V3-glycan antibodies against HIV-1 in nonhuman primatesIgnacio Relano-Rodriguez, Jianqiu Du, Zi Jie Lin, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Nature Communications|May 18, 2018
Structure of a cleavage-independent HIV Env recapitulates the glycoprotein architecture of the native cleaved trimerAnita Sarkar, Shridhar Bale, Anna-Janina Behrens, et al.
Nature Microbiology|August 27, 2016
Structures of Ebola virus GP and sGP in complex with therapeutic antibodiesJesper Pallesen, Charles D Murin, Natalia de Val, et al.
Plos Pathogens|May 11, 2018
Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteinsTorben Schiffner, Jesper Pallesen, Rebecca A Russell, et al.
Trends in Biotechnology|June 19, 2026
Engineering single-dose plasmid DNA for sustained in vivo delivery of designer incretinsEbony N Gary, Yangcheng Gao, Casey E Hojecki, et al.
Cell Reports|September 26, 2019
Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTDNianshuang Wang, Osnat Rosen, Lingshu Wang, et al.
Cell Reports|May 23, 2019
The Chimpanzee SIV Envelope Trimer: Structure and Deployment as an HIV Vaccine TemplateRaiees Andrabi, Jesper Pallesen, Joel D Allen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2017
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigenJesper Pallesen, Nianshuang Wang, Kizzmekia S Corbett, et al.
Nature Medicine|October 21, 2025
Safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies in healthy adults: a phase 1 trialPablo Tebas, Ami Patel, Joseph T Agnes, et al.
Plos Pathogens|November 8, 2019
Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteinsJose A Quiroz, Ryan J Malonis, Larissa B Thackray, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Rapid elicitation of a new class of neutralizing N332-glycan independent V3-glycan antibodies against HIV-1 in nonhuman primatesIgnacio Relano-Rodriguez, Jianqiu Du, Zi Jie Lin, et al.
Pageof 4